Last --
Change Today 0.00 / 0.00%
Volume 0.0
4924 On Other Exchanges
Symbol
Exchange
4924 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

dr ci:labo co ltd (4924) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for DR CI:LABO CO LTD (4924)

Related News

No related news articles were found.

dr ci:labo co ltd (4924) Related Businessweek News

No Related Businessweek News Found

dr ci:labo co ltd (4924) Details

Dr. Ci:Labo Co., Ltd. is engaged in the conception, development, manufacture, and sale of cosmetics, health foods, beauty care devices, and other products. The company offers various skin care cosmetics products, including low-stimulant cosmetics and anti-aging products for people of various ages; and nutritional supplements, food products, and other products. It sells its products under the Dr.Ci:Labo, Labo Labo, and Genomer brand names through mail order; and wholesale to drug stores, pharmacies, cosmetics shops, and other retail stores, as well as through its Dr. Ci:Labo corners in directly operated stores, department stores, and shopping centers. The company primarily operates in the United States, Taiwan, Hong Kong, Singapore, Malaysia, South Korea, and Japan. Dr. Ci:Labo Co., Ltd. was founded in 1999 and is headquartered in Tokyo, Japan.

736 Employees
Last Reported Date: 10/22/13
Founded in 1999

dr ci:labo co ltd (4924) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

dr ci:labo co ltd (4924) Key Developments

Dr. Ci:Labo Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended April 30, 2014; Provides Year End Dividend and Earnings Guidance for the Year Ending July 31, 2014

Dr. Ci:Labo Co., Ltd. reported consolidated earnings results for the nine months ended April 30, 2014. For the period, the company reported net sales of ¥25,521 million, operating income of ¥5,353 million, ordinary income of ¥5,394 million and net income of ¥3,304 million or ¥132.56 per share compared to net sales of ¥24,104 million, operating income of ¥4,859 million, ordinary income of ¥5,050 million and net income of ¥3,127 million or ¥125.49 per share reported in the same period last year. Net income before taxes was ¥5,391.1 million against ¥5,036.3 million reported last year. For the year ending July 31, 2014, the company provided year end dividend forecast of ¥81.00 per share compared to ¥8,000.00 per share declared last year. For the year ending July 31, 2014, the company expected to report net sales of ¥36,800 million, operating income of ¥8,400 million, ordinary income of ¥8,400 million and net income of ¥5,100 million or ¥204.59 per share.

Dr. Ci:Labo Co., Ltd. to Report Q3, 2014 Results on Jun 10, 2014

Dr. Ci:Labo Co., Ltd. announced that they will report Q3, 2014 results on Jun 10, 2014

Dr. Ci:Labo Co., Ltd. to Report Q2, 2014 Results on Mar 10, 2014

Dr. Ci:Labo Co., Ltd. announced that they will report Q2, 2014 results on Mar 10, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4924:JP ¥3,725.00 JPY +10.00

4924 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4924.
View Industry Companies
 

Industry Analysis

4924

Industry Average

Valuation 4924 Industry Range
Price/Earnings 18.6x
Price/Sales 2.6x
Price/Book 4.3x
Price/Cash Flow 18.9x
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DR CI:LABO CO LTD, please visit www.ci-labo.com/ir/e/index.html. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.